641 / 1024
Select group of patients that benefit from aggressive local
treatment for oligometastatic disease
2y
63%
2y
57%
2y
86%
Sole CV, Lopez Guerra JL, et al. Clin Transl Oncol. 2013
Toxicity (N=28) Grade I
Grade II
Grade III
Pneumonitis
11 (39%)
3 (11%)
1 (4%)
Chest wall pain
6 (21%)
Skin
6 (21%)
Esophagitis
3 (11)